Alison Moore - Chief Technical Officer, Allogene Therapeutics, Inc

As of March 30, 2021


Alison Moore Net Worth

  • Net worth is estimated to be at least $11.71M
  • Owns at least 102,574 units of Allogene Therapeutics, Inc stock
  • Sold an estimated value of $9.71M in the last 2 years at Allogene Therapeutics, Inc

Alison Moore Compensation at Allogene Therapeutics, Inc in 2020

  • Earned a $440,000 salary
  • Rewarded $561,176 in stock value and options
  • Received a total compensation of $2,483,819

Alison Moore Trading

  • Largest purchase of shares was 48,828 units , worth over $110.84K on June 5, 2019
  • Largest sale of shares was 44,574 units , worth over $1.83M on October 9, 2020
  • In total has made about 13 transactions over 2 years
  • Usually trades in March, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Alison Moore Mailing Address

  • Mailing address is C/o Allogene Therapeutics, Inc. 210 East Grand Avenue South San Francisco CA 94080 CA

Allogene Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
David Chang, M.D., Ph.D. 2020 $675,000 - - $6,550,535 $506,250 $83,256 $7,815,041
David Chang, M.D., Ph.D. 2019 $600,000 - $4,651,970 $5,327,140 $363,000 $250,000 $11,192,110
David Chang, M.D., Ph.D. 2018 $362,413 - $8,948,152 $3,070,331 $217,641 $250,000 $12,848,537
Eric Schmidt, Ph.D. 2020 $440,000 - $561,176 $1,262,643 $220,000 - $2,483,819
Eric Schmidt, Ph.D. 2019 $425,000 - $1,328,366 $1,519,700 $187,000 - $3,460,066
Eric Schmidt, Ph.D. 2018 $201,232 - - $2,299,658 $88,099 - $2,588,989
Rafael Amado, M.D. 2020 $510,000 $75,000 $561,176 $1,262,643 $255,000 - $2,663,819
Rafael Amado, M.D. 2019 $145,833 - $4,249,976 $2,759,623 $71,726 $225,000 $7,452,158
Alison Moore, Ph.D. 2020 $440,000 - $561,176 $1,262,643 $220,000 - $2,483,819
Alison Moore, Ph.D. 2019 $425,000 - $996,275 $1,519,700 $187,000 - $3,127,975
Alison Moore, Ph.D. 2018 $233,265 - - $1,401,225 $102,124 $100,000 $1,836,614
Veer Bhavnagri 2020 $425,000 - $537,490 $1,211,953 $212,500 $9,385 $2,396,328
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1737287/000173728721000013/allo-20210423xdef14axproxy.htm

Allogene Therapeutics, Inc Insider Trading

  • The most recent transaction was 5,000 units sold on September 17, 2021 by Veer Bhavnagri worth over $123.84K
  • In the last 3 years, insiders at Allogene Therapeutics, Inc sold an estimated value of $150.82M and bought an estimated value of $31M
  • The most active traders are David Chang, President and CEO,  Veer Bhavnagri, General Counsel,  and Alison Moore, Chief Technical Officer
  • Insider trading is most common in March, with the busiest year in 2020

Allogene Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1